131 related articles for article (PubMed ID: 16638687)
1. Preparation and in vitro release of dual-drug resinates containing equivalent content dextromethorphan and diphenhydramine.
Akkaramongkolporn P; Kulvanich P; Pathipvanich M
Drug Dev Ind Pharm; 2006 Apr; 32(4):483-96. PubMed ID: 16638687
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets.
Malladi M; Jukanti R; Nair R; Wagh S; Padakanti HS; Mateti A
Acta Pharm; 2010 Sep; 60(3):267-80. PubMed ID: 21134862
[TBL] [Abstract][Full Text] [Related]
3. Preparation of codeine-resinate and chlorpheniramine-resinate sustained-release suspension and its pharmacokinetic evaluation in beagle dogs.
Zeng HX; Cheng G; Pan WS; Zhong GP; Huang M
Drug Dev Ind Pharm; 2007 Jun; 33(6):649-65. PubMed ID: 17613029
[TBL] [Abstract][Full Text] [Related]
4. Microencapsulation of chlorpheniramine maleate-resin particles with crosslinked chitosan for sustained release.
Huang RG; Schwartz JB; Ofner CM
Pharm Dev Technol; 1999 Jan; 4(1):107-15. PubMed ID: 10027219
[TBL] [Abstract][Full Text] [Related]
5. Effect of polysulfonate resins and direct compression fillers on multiple-unit sustained-release dextromethorphan resinate tablets.
Pongjanyakul T; Priprem A; Chitropas P; Puttipipatkhachorn S
AAPS PharmSciTech; 2005 Sep; 6(2):E190-7. PubMed ID: 16353977
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of taste-masked dextromethorphan oral disintegrating tablet.
Samprasit W; Opanasopit P; Akkaramongkolporn P; Ngawhirunpat T; Wongsermsin K; Panomsuk S
Pharm Dev Technol; 2012; 17(3):315-20. PubMed ID: 21142821
[TBL] [Abstract][Full Text] [Related]
7. Taste mask, design and evaluation of an oral formulation using ion exchange resin as drug carrier.
Bhise K; Shaikh S; Bora D
AAPS PharmSciTech; 2008; 9(2):557-62. PubMed ID: 18491233
[TBL] [Abstract][Full Text] [Related]
8. Ion-exchange resins as drug delivery carriers.
Guo X; Chang RK; Hussain MA
J Pharm Sci; 2009 Nov; 98(11):3886-902. PubMed ID: 19226637
[TBL] [Abstract][Full Text] [Related]
9. Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix.
Jeong SH; Park K
Int J Pharm; 2008 Sep; 361(1-2):26-32. PubMed ID: 18565701
[TBL] [Abstract][Full Text] [Related]
10. Influence of methacrylic acid and hydroxypropylmethyl cellulose on the tablet properties and in vitro release of dextromethorphan hydrobromide.
Takka S; Singh Bharaj S; Sakr A
Pharmazie; 2003 Dec; 58(12):886-90. PubMed ID: 14703967
[TBL] [Abstract][Full Text] [Related]
11. Dual ambroxal and chlorpheniramine resinate as an alternative carrier in concurrent resinate administration.
Akkaramongkolporn P; Ngawhirunpat T
Pharmazie; 2003 Mar; 58(3):195-9. PubMed ID: 12685813
[TBL] [Abstract][Full Text] [Related]
12. Effect of sampling procedures of release testing on drug release and scale-up production feasibility of multiple-unit dextromethorphan resinate tablets: a technical note.
Pongjanyakul T
AAPS PharmSciTech; 2007 Dec; 8(4):E117. PubMed ID: 18181538
[TBL] [Abstract][Full Text] [Related]
13. Effect of a pharmaceutical cationic exchange resin on the properties of controlled release diphenhydramine hydrochloride matrices using Methocel K4M or Ethocel 7cP as matrix formers.
Akkaramongkolporn P; Ngawhirunpat T; Nunthanid J; Opanasopit P
AAPS PharmSciTech; 2008; 9(3):899-908. PubMed ID: 18668370
[TBL] [Abstract][Full Text] [Related]
14. A new hydrophilic interaction liquid chromatographic (HILIC) procedure for the simultaneous determination of pseudoephedrine hydrochloride (PSH), diphenhydramine hydrochloride (DPH) and dextromethorphan hydrobromide (DXH) in cough-cold formulations.
Ali MS; Ghori M; Rafiuddin S; Khatri AR
J Pharm Biomed Anal; 2007 Jan; 43(1):158-67. PubMed ID: 16887317
[TBL] [Abstract][Full Text] [Related]
15. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex.
Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Sila-on W; Opanasopit P
Drug Dev Ind Pharm; 2013 Nov; 39(11):1672-80. PubMed ID: 23078590
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Chloroquine Resinate Feasibility and In Vitro Taste Masking Evaluation for Pediatric Formulations.
Guimarães TF; Vital ICF; de Sousa EGR; Boniatti J; Bandini TB; Carr O; Oliveira ON; Shimizu FM; da Fonseca LB; Viçosa AL
AAPS PharmSciTech; 2022 Feb; 23(2):69. PubMed ID: 35112208
[TBL] [Abstract][Full Text] [Related]
17. Dextromethorphan hydrobromide preparations on the Belgian market--a comparative study.
Fierens C; Corthout J
J Pharm Belg; 2009 Mar; (1):15-7. PubMed ID: 19391437
[TBL] [Abstract][Full Text] [Related]
18. Abuse liability and stimulant properties of dextromethorphan and diphenhydramine combinations in rats.
Jun JH; Thorndike EB; Schindler CW
Psychopharmacology (Berl); 2004 Mar; 172(3):277-82. PubMed ID: 14634714
[TBL] [Abstract][Full Text] [Related]
19. Fabrication and evaluation for the novel ranitidine hydrochloride resinates and calculation of the kinetics and thermodynamics parameter for the ion exchange process.
Yang Y; Du Y; He H; Yu Y; Li D; Liu H
Pak J Pharm Sci; 2021 Sep; 34(5):1715-1722. PubMed ID: 34803007
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization of clonidine hydrochloride resinates and investigation of the kinetics and thermodynamics of the ion exchange process.
Liu H; Lai X; Chen C; Feng Y; Yu Y; Yin X; He H
Pak J Pharm Sci; 2022 May; 35(3):721-729. PubMed ID: 35791469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
